Reimbursement

Data from a recent survey reflect a resounding shift toward the role of pharmacies becoming sites for primary care.

The Amazon Pharmacy service will also have pharmacists on-call 24/7, according to the announcement.

During the COVID-19 pandemic, patients were able to utilize telehealth services to receive care more conveniently, which may reduce the cost of care.

Key trends such as consolidation create an opportunity for independent pharmacies with a community-based approach.

Energy crisis in Europe puts strain on production and could have ramifications that extend beyond the continent's borders.

Patient financial/co-pay assistance is usually a component of providing infusion services and practices need to make sure it’s carefully managed to prevent financial hardship to patients.

Digitizing hub processes can create an efficient and effective tech-driven patient access strategy speeding access to lifesaving therapies.

Patient-centric models of medication delivery that provide cost, transparency, convenience, and accessibility solutions are vital for patients to successfully navigate the current health care system.

Survey shows pharmacies could implement more point-of-care testing and have a large pool of willing participants.

Financial assistance platforms improve patient outcomes and the pharmacy bottom line.

New tools and technology applications proliferate as multiple, industrywide shifts take hold in pharmacy.

It is important that our national and even state and local professional pharmacy organizations are coming together as a voice for the profession.

Despite a limited understanding about access to oral anticancer drugs, new research finds challenges in patient and clinician decision-making.

Five crucial steps pharmacies can take to enhance patient engagement and lower operational costs.

Larger corporations might consider holding some sort of financial literacy training for pharmacy employees.

Getting payers on board will be key to national biosimilar cost-savings potential.

Diversity, equity, and inclusion programs in pharmacy can lead to better health outcomes for patients.

Data show that despite declines in visit rates to federally qualified health centers, patients with psychological disorder diagnoses during COVID-19 did well when telemedicine was available.

Decision on payment reductions looks fleeting as ruling also provides HHS with instructions on cost-cutting goals.

As a new year approaches, pharmacists have so much to look back on and be grateful for, and a world of opportunity in front of them. Here are a few things to be ready for right away in 2023.

There is at least a 28% difference in the amount of licensed US substance use disorder facilities that accept Medicaid and private insurance compared to Medicare, according to new research.

Generic small molecule drugs take advantage of abbreviated approval pathways and have markedly lower development costs compared to their reference products.

Study suggests states maintaining higher health care expenditures are more attentive to price transparency initiatives and tend to adopt all-payer claims databases.

States with a higher prevalence of Medicaid patients with type 2 diabetes were found to have lower use ratio of glucose-lowering agents with known cardiovascular benefits.

A physician working in the field of palliative care discusses how pharmacists and physicians can work together to help address issues pertaining to polypharmacy through deprescribing.

The framework includes 6 domains designed to immediately empower students in community pharmacies.

Poster presentations and speaking sessions at NASP showed the importance of clinical pharmacists in ambulatory care and opportunities to expand specialty pharmacy services in ambulatory care.

Providers working in collaboration with pharmacists saw significantly more patients than providers who worked independently.

Assessment follows state board of pharmacy ruling against request to open an in-office pharmacy.

NCPA will appeal Express Scripts’ decision to reduce access to medications, following a contract with the Department of Defense.